Catherine Kissel

Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

S. Gauthier, C. Kissel, S. Suissa, 1990, The New England journal of medicine.